Development of Small Molecule Drugs – From the Clinic to the Market

Drug substance

In this webinar, we present an overview of the development of a small molecule drug focusing on the typical needs and requirements for an API manufacturer at each stage of the lifecycle.

We then present a case study of how a CDMO, such as Cambrex, has the expertise to support customers at all stages from early development to commercial launch.